250,000 patients to benefit from free access to short-course TB preventive treatment
Support from a global consortium will expand access to shorter TB prevention options, help advance efforts towards TB elimination across seven counties The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced on 23 March that it will provide 250,000 patient courses of short course rifapentine-based preventive treatment regimens to seven countries to help…